Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Salgenx Revolutionizes Battery Technology with Self-Assembly and Self-Healing Cathode Materials
    Salgenx Revolutionizes Battery Technology with Self-Assembly and Self-Healing Cathode Materials World News
  • Breakthrough semi-solid state battery technology providing significant weight advantages over traditional Generators
    Breakthrough semi-solid state battery technology providing significant weight advantages over traditional Generators World News
  • Senior Official for Global Women’s Issues Fotovat Travels to New York
    Senior Official for Global Women’s Issues Fotovat Travels to New York World News
  • Monument Sotheby’s International Realty Invests in Substantial Partnership With Ocean Atlantic Sotheby’s International Realty
    Monument Sotheby’s International Realty Invests in Substantial Partnership With Ocean Atlantic Sotheby’s International Realty Business
  • Ratikant Kanungo – A Social Worker in Spotlight
    Ratikant Kanungo – A Social Worker in Spotlight World News
  • Cloudbric listed in the Spring 2023 Web Application Firewall (WAF) report by G2
    Cloudbric listed in the Spring 2023 Web Application Firewall (WAF) report by G2 Business
  • Exec Capital launches International Team
    Exec Capital launches International Team Business
  • War Day 182: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych  & #Feygin
    War Day 182: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma

TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma

Posted on March 15, 2023 By NewsEditor
TTC Oncology LLC Signs a Collaboration Agreement With Lantern PharmaTTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma

EDINA, Minn., March 15, 2023 (Newswire.com) - TTC Oncology ("TTC" or the "Company") announced the signing of a Collaboration Agreement (the "Agreement") with Lantern Pharma Inc. ("LTRN") to expand the clinical development of the TTC drug candidate TTC-352. The Phase-2 ready candidate, TTC-352, is an orally available small molecule being developed as a treatment for patients with metastatic estrogen receptor-positive ("ER+") breast cancer who have failed two or more prior therapies. TTC-352 is a first-in-class selective human ER partial agonist (ShERPA) that in metastatic disease causes ER to induce breast cancer cell death.

The collaboration will be powered by Lantern's artificial intelligence (AI) platform, RADR®, and its 25+ billion oncology-focused data points, 200+ advanced ML algorithms, as well as its four multi-faceted AI drug discovery and development modules. The initial aims of the collaboration will be to 1) identify biomarker or gene signatures to power potential patient selection for an upcoming TTC-352 Phase 2 clinical trial, 2) further characterize TTC-352's mechanism of action, and 3) discover additional treatment indications for TTC-352.

Breast cancer afflicts approximately 2.1 million women in the U.S. yearly with the majority of these cases being ER+, in which ER promotes tumor growth. Patients with ER+ breast cancer are initially treated with endocrine therapy, which blocks the tumorigenic actions of ER. Unfortunately, almost half of all patients who undergo endocrine therapy develop endocrine-resistant metastatic disease and will need chemotherapy as a last resort. TTC-352 provides an alternative approach without the toxicity associated with chemotherapy. 

Under the terms of the collaboration, Lantern Pharma is receiving an exclusive right to license TTC-352, including any collaboration intellectual property (IP), during an exclusive option period. Additionally, Lantern and TTC will each participate in upfront, milestone, and royalty payments in the event a third party licenses IP resulting from the collaboration. No further financial details were disclosed.

About Lantern Pharma

Lantern Pharma ("LTRN") is a clinical-stage oncology-focused biopharmaceutical company leveraging its proprietary RADR® AI and machine learning platform to discover biomarker signatures that identify patients most likely to respond to its pipeline of genomically-targeted therapeutics. By targeting drugs to patients whose genomic profile identifies them as having the highest probability of benefiting from the drug, Lantern's approach represents the potential to deliver best-in-class outcomes. For more information, please visit the company's website at www.lanternpharma.com.

About TTC Oncology LLC

TTC Oncology is an emerging biotechnology company founded in 2015. TTC Oncology's mission is to develop and bring to market a novel, small-molecule therapy, TTC-352, to address the unmet needs of breast cancer patients. TTC has a license from the University of Illinois at Chicago covering the therapy. https://ttconcology.com/ TTC is currently raising funds to complete Phase II studies. 

Contact Information:
Joe Cunningham
CFO
[email protected]
6129911778


Original Source: TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma

The post TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma first appeared on Social Gov.

Business

Post navigation

Previous Post: Diverge Health Launched to Build Upon a Decade of Experience Serving Underserved Patients in New York
Next Post: Augmenta acquired by CNH Industrial

Related Posts

  • World Youth Forum Launches Large Package of Development Initiatives and Projects
    World Youth Forum Launches Large Package of Development Initiatives and Projects Business
  • Sun Sets on 123SignUp While EZSignUp Emerges
    Sun Sets on 123SignUp While EZSignUp Emerges Business
  • Midnight Gaming Corporation and Compass Arena Chicago, Complete Transformative Booking Services Agreement
    Midnight Gaming Corporation and Compass Arena Chicago, Complete Transformative Booking Services Agreement Business
  • Custom Legal Marketing Wins W3 Award for Steinberg Law Firm’s Website
    Custom Legal Marketing Wins W3 Award for Steinberg Law Firm’s Website Business
  • Summit Group Solutions, LLC Names New Senior Director of Operations
    Summit Group Solutions, LLC Names New Senior Director of Operations Business
  • Designer Kanchan Garg launches HAXOR, Elderly Clothing Collections Embracing the Seniors
    Designer Kanchan Garg launches HAXOR, Elderly Clothing Collections Embracing the Seniors Business
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Apr    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Global Distribution Transformers Market to Reach USD 56.4 Billion by 2035, Driven by Grid Modernization and RenewablesMay 31, 2025
  • AUVSI Announces SolidIntel as New Supply Chain Monitoring Partner for Green UASMay 31, 2025
  • Key Drivers, Trends, Growth Opportunities & Forecast 2025-2034May 30, 2025
  • Unprecedented Opportunities for First-Time Home Buyers in the Fraser ValleyMay 30, 2025
  • The ARON M80 Flying Ship Takes FlightMay 30, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • War Day 183: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych  & #Feygin
    War Day 183: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Green Tea Market Size, Share, Revenue, Trends And Drivers For 2024-2033
    Green Tea Market Size, Share, Revenue, Trends And Drivers For 2024-2033 World News
  • Cell Expansion Market Segments, Drivers, Restraints, And TrendsFor 2024-2033
    Cell Expansion Market Segments, Drivers, Restraints, And TrendsFor 2024-2033 Business
  • Powder Alert! Western Massachusetts Gears Up for Record Snowfall and Budget-Friendly Winter Fun
    Powder Alert! Western Massachusetts Gears Up for Record Snowfall and Budget-Friendly Winter Fun World News
  • TELF AG Reports that Livista Energy Europe is set to Build Low-Carbon Lithium Refinery in Germany
    TELF AG Reports that Livista Energy Europe is set to Build Low-Carbon Lithium Refinery in Germany World News
  • Caesars Southern Indiana Dramatically Lowers KYC/EDD Investigation Time from 8hrs to 45mins
    Caesars Southern Indiana Dramatically Lowers KYC/EDD Investigation Time from 8hrs to 45mins World News
  • The 2023 New Year’s Anthem
    The 2023 New Year’s Anthem World News
  • Joint Statement from Foreign Ministers on the Situation for Women and Girls in Afghanistan on International Women’s Day
    Joint Statement from Foreign Ministers on the Situation for Women and Girls in Afghanistan on International Women’s Day World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .